Inactive Instrument

Highlights Tonix Pharmaceuticals Holding Corp Nasdaq

Equities

US8902604094

Highlights

Unlock all the news: Be the first to know and act before the market!

Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge	07-09	MT
Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours	07-08	MT
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya? for the Management of Fibromyalgia	07-08	CI
Tonix Pharmaceuticals Receives Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program	07-01	CI
Tonix Pharmaceuticals Closes $4 Million Offering	06-28	MT
Top Midday Decliners	06-27	MT
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data	06-27	MT
Top Premarket Decliners	06-27	MT
Tonix Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule	06-26	MT
Tonix Pharmaceuticals Holding Corp. Presents Vaccine Platform Data in Keynote Talk At the Vaccine Congress 2024	06-25	CI
Tonix Pharmaceuticals Holding Corp. Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya for the Management of Fibromyalgia	06-20	CI
Top Midday Decliners	06-12	MT
Wall Street Set to Open Higher Wednesday as Key Inflation Data Lower Than Expected	06-12	MT
US Futures Slightly Higher Ahead of Fed's Rate Decision, Key Inflation Data	06-12	MT
Top Premarket Decliners	06-12	MT
Tonix Pharmaceuticals Plans Common Stock Offering to Fund New Drug Application for Fibromyalgia; Shares Fall After Hours	06-11	MT
Reverse Split: 1 of 32	06-09	FA
Reverse Split: 1 of 32	06-09	FA
Tonix Pharmaceuticals to Implement 1-for-32 Reverse Stock Split -- Shares Fall	06-06	MT
Tonix Pharmaceuticals Holding Corp. Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500	06-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Tonix Pharmaceuticals Holding Corp Nasdaq

Equities

US8902604094

Highlights

Filters